Risk of myopathy with statin and fibrate treatment
Abstract
In this Drug Points article the author describes a case of a patient being placed at increased risk of myopathy when prescribed a fibrate in addition to her statin for hypercholesterolaemia. Copyright © 2007 Wiley Interface Ltd
Digital Object Identifier (DOI)
10.1002/psb.58 About DOI
Login/Logout
Journal Menu
- Home
- News
- Current Issue
- Archive Issues
- Learning Central
- Ask Prescriber
- Prescriber Blog
- Forthcoming Events
- Supplements
- Wiley Job Network






